Cagrilintide 10mg Peptides
Engineered for disciplined research, this vial delivers dependable peptide integrity for consistent, repeatable results.
This cagrilintide research peptide is supplied as a lyophilized vial for laboratory reconstitution, providing a total strength of 10mg. The format is a stable, dry powder with no flavor or additives, designed for controlled handling and precise method development. As an amylin-pathway peptide, cagrilintide is presented for qualified research applications where reliability, traceability, and purity are essential.
- Each vial contains 10mg of Cagrilintide, investigated for its interaction with amylin receptors and its relevance to satiety signaling, gastric emptying dynamics, and broader metabolic research pathways.
In use, the lyophilized presentation supports accurate, protocol-aligned preparation within qualified laboratory environments. Researchers appreciate the clean reconstitution profile and compatibility with standard analytical workflows, allowing careful calibration, aliquoting, and study design without unnecessary excipients. The focus is on methodical setup and reproducible data capture, whether the objective is mechanistic evaluation, assay development, or exploratory modeling under institutional guidelines.
Every vial reflects an uncompromising approach to quality. Peptide Scientific Labs prioritizes controlled manufacturing practices, rigorous in-process checks, and analytical verification of identity and purity (e.g., HPLC and LC-MS methods). Lots are documented and traceable to support transparency from receipt through protocol execution. Packaging is designed for secure transport and dependable storage, helping maintain peptide integrity from arrival to end of study. This material is intended strictly for laboratory research and is not for human or veterinary use, diagnostic procedures, or therapeutic applications.
Choosing Peptide Scientific Labs means selecting a USA-based supplier centered on consistency, clarity, and compliance. Our team emphasizes careful handling, clear documentation, and dependable specifications so research teams can move forward with confidence. If your work depends on precise peptide performance and the assurance of professional standards, this cagrilintide 10mg lyophilized vial is built to support rigorous, high-quality research.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is Cagrilintide?
Cagrilintide is a long-acting amylin analog used in metabolic research. It belongs to the incretin-adjacent appetite-regulation space rather than the classic growth-hormone or repair-peptide category. On a product page, the accurate framing is that it is a research compound studied for metabolic signaling, not an approved consumer-use peptide.
What is Cagrilintide typically studied for?
Cagrilintide is usually studied in relation to appetite regulation, satiety signaling, gastric-emptying effects, and body-weight change in experimental models. It is also often discussed alongside GLP-1-based research because both areas intersect around energy intake and metabolic control.
What are GLP peptides?
GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.
A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Peptide Scientific Labs are lyophilized research materials intended solely for in vitro laboratory investigation.
How do GLP analogs differ from native GLP hormones?
Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.
This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.
What is the difference between GLP-1, GLP-2, and GLP-3 in research?
GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.
GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.
This Product Contains
